Stay updated on BMS-986226 Immunotherapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.

Latest updates to the BMS-986226 Immunotherapy Combo Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study details or layout.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedNo additions or deletions detected; the page content appears unchanged between the two screenshots.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 and the government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedA government funding status notice has been added at the top of the page, and the page revision has been updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now shows a glossary option and updates several labels, including capitalization changes in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', as well as adding a new 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BMS-986226 Immunotherapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986226 Immunotherapy Combo Clinical Trial page.